Crystalline form F of Imatinib mesylate

Details Crystalline form F of Imatinib mesylate Crystalline form F of Imatinib mesylate

2011-02-22

2011-02-22

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C424S465000, C544S331000, C544S359000, C546S274100

Reexamination Certificate

active

07893076

ABSTRACT:
The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, certain processes for their preparation, pharmaceutical compositions containing these crystal forms, their use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, especially humans.

REFERENCES:
patent: 99/03854 (1999-01-01), None
patent: 2004/106326 (2004-12-01), None
patent: 2005/077933 (2005-08-01), None
patent: 2005/095379 (2005-10-01), None
patent: 2006/024863 (2006-03-01), None
patent: 2006/048890 (2006-05-01), None
patent: 2006/054314 (2006-05-01), None
patent: 2007/023182 (2007-03-01), None

Affiliated with

Also associated with

Rating

Crystalline form F of Imatinib mesylate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline form F of Imatinib mesylate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form F of Imatinib mesylate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2643010